Extended indication Enkelvoudige ziekte modificerende therapie bij zeer actieve relapsing remitting multiple sclerose in
Therapeutic value Possible equal value
Registration phase Registered

Product

Registration

Therapeutic value

Expected patient volume per year

Expected cost per patient per year

Potential total cost per year

Off label use

Indication extension

Other information